The Application of Microfluidic Chips in Primary Urological Cancer: Recent Advances and Future Perspectives
Authors:
Open Access
- 19 May 2025
- journal article
- review article
- Published by Wiley in Smart Medicine
- Vol. 4 (2) , e70010
Abstract
The research of primary urological cancers, including bladder cancer (BCa), prostate cancer (PCa), and renal cancer (RCa), has developed rapidly. Microfluidic technology provides a good variety of benefits compared to the heterogeneity of animal models and potential ethical issues of human study. Microfluidic technology and its application with cell culture (e.g., organ‐on‐a‐chip, OOC) are extensively used in urological cancer studies in preclinical and clinical settings. The application has provided diagnostic and therapeutic benefits for patients with urological diseases, especially by evaluating biomarkers for urinary malignancies. In this review, we go through the applications of OOC in BCa, Pca and Rca, and discuss the prospects of reducing the cost and improving the repeatability and amicability of the intelligent integration of urinary system organ chips.Keywords
This publication has 172 references indexed in Scilit:
- Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape RoutesClinical Cancer Research, 2009
- Monolayer and Spheroid Culture of Human Liver Hepatocellular Carcinoma Cell Line Cells Demonstrate Distinct Global Gene Expression Patterns and Functional PhenotypesTissue Engineering Part A, 2009
- Intravesical Pharmacotherapy for Non–Muscle-Invasive Bladder Cancer: A Critical Analysis of Currently Available Drugs, Treatment Schedules, and Long-Term ResultsEuropean Urology, 2008
- Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogelsThe FASEB Journal, 2006
- Optical Deformability as an Inherent Cell Marker for Testing Malignant Transformation and Metastatic CompetenceBiophysical Journal, 2005
- Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophyGlycobiology, 2004
- Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.2001
- BCG immunotherapy for superficial bladder cancerJournal of the Royal Society of Medicine, 2001
- URINE CYTOLOGYUrologic Clinics of North America, 2000
- Apoptosis of Renal Cortical Cells in the Hemolytic-Uremic Syndrome: In Vivo and In Vitro StudiesInfection and Immunity, 1998